SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Study Points to Genetic Driver of Severe Asthma, Cincinnati Children’s Hospital Medical Center Study
August 30, 2010
 · 
1 min read
Drug Development
Body Clock Mouse Study Suggests New Drug Potential, Manchester Metropolitan University Study
August 24, 2010
 · 
1 min read
Drug Development
Virus Linked to Chronic Fatigue Syndrome, Whitemore Peterson Institute Study
August 24, 2010
 · 
1 min read
Drug Development
One Company, The Wistar Institute, Aims to Re-purpose a Smallpox Vaccine to Battle HIV
August 24, 2010
 · 
1 min read
Drug Development
Scientists Identify New Drug Strategy Against Fragile X Syndrome, Emory University School of Medicine Study
August 24, 2010
 · 
1 min read
Drug Development
How Arthritis Fighter May Help Alzheimer’s, University of South Florida Study
August 24, 2010
 · 
1 min read
Drug Development
Studies from Utrecht University, Utrecht Institute for Pharmaceutical Science in the Area of Immunization Published
August 23, 2010
 · 
1 min read
Drug Development
Novel ‘Antisense’ Therapies Protect Primates from Lethal Ebola and Marburg Viruses, AVI BioPharma, Inc. and US Army Study
August 23, 2010
 · 
1 min read
Drug Development
Researchers Identify Two FDA Approved Drugs That May Fight HIV, University of Minnesota Study
August 23, 2010
 · 
1 min read
Drug Development
New Molecular Signaling Cascade Increases Glucose Uptake, Harvard University and University of Copenhagen Study
August 20, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Flare Therapeutics Presents Preclinical Data that Show Potential of Novel PPARG Inhibitors to Treat Urothelial Cancer at 2022 EORTC-NCI-AACR Symposium
October 26, 2022
 · 
4 min read
Drug Development
Theseus Pharmaceuticals Presents Preclinical Data Characterizing THE-349, its Fourth-Generation EGFR Inhibitor in Development for NSCLC, at the 34th EORTC-NCI-AACR Symposium
October 26, 2022
 · 
8 min read
Drug Development
TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma
October 26, 2022
 · 
6 min read
Drug Development
Cogent Biosciences to Showcase Precision Therapy Pipeline at the EORTC-NCI-AACR Annual Meeting
October 26, 2022
 · 
5 min read
Drug Development
Nuvalent Announces New Preclinical Data for Selective Kinase Inhibitors NVL-330 and NVL-655
October 26, 2022
 · 
9 min read
Drug Development
Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Symposium
October 26, 2022
 · 
5 min read
Drug Development
Scorpion Therapeutics Presents Preclinical Proof-of-Concept Data for STX-721, a Next-Generation Exon 20 Mutant EGFR Inhibitor, at the EORTC-NCI-AACR Symposium 2022
October 26, 2022
 · 
5 min read
Drug Development
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease
October 25, 2022
 · 
7 min read
Drug Development
Lantern Pharma to Present New Preclinical Data at Three Upcoming Scientific Conferences
October 25, 2022
 · 
5 min read
Drug Development
Longhorn Vaccines and Diagnostics Reports Composite Peptide Vaccines Generate Immune Responses to Both Influenza and Coronavirus
October 24, 2022
 · 
4 min read
Drug Development
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update
October 24, 2022
 · 
7 min read
Drug Development
Monte Rosa Therapeutics to Present at 5th Annual Targeted Protein Degradation Summit and 34th EORTC-NCI-AACR Symposium
October 20, 2022
 · 
7 min read
Drug Development
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury Pre-clinical trial
October 20, 2022
 · 
7 min read
Drug Development
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
October 19, 2022
 · 
5 min read
Drug Development
Enanta Pharmaceuticals Presents New Preclinical Data for EDP-235, its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed for the Treatment of COVID-19 at IDWeek™ 2022
October 19, 2022
 · 
5 min read
Drug Development
Preclinical Data from iECURE’s GTP-506 Demonstrates Potential for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
October 19, 2022
 · 
6 min read
Drug Development
Iterion Therapeutics Announces Results from Preclinical Study of Tegavivint in Beta-Catenin Mutant Hepatocellular Carcinoma to be Presented at the 34th EORTC-NCI-AACR Symposium 2022
October 18, 2022
 · 
5 min read
Drug Development
Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
October 18, 2022
 · 
6 min read
Drug Development
EvolveImmune Therapeutics to Present New Preclinical Data from Novel Costimulatory T Cell Engager Platform at Upcoming Scientific Conferences
October 18, 2022
 · 
2 min read
Drug Development
POINT Biopharma Publishes Preclinical Data for Actinium-Labelled PNT2001, a Next-Generation PSMA Ligand, at EANM’s Annual Congress
October 17, 2022
 · 
6 min read
Load More